Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register

Peer Review reports

Original Submission
21 Jun 2018	Submitted	Original manuscript
2 Aug 2018	Reviewed	Reviewer Report - Kristina Lee Butler
6 Aug 2018	Reviewed	Reviewer Report - Sarah Cook
2 Oct 2018	Author responded	Author comments - Sofia Axia Karlsson
Resubmission - Version 2
2 Oct 2018	Submitted	Manuscript version 2
7 Nov 2018	Author responded	Author comments - Sofia Axia Karlsson
Resubmission - Version 3
7 Nov 2018	Submitted	Manuscript version 3
Publishing
12 Nov 2018	Editorially accepted
28 Nov 2018	Article published	10.1186/s12913-018-3707-4

Back to article page